title: Translational and Therapeutic Approaches to the Understanding and Treatment of Dyslipidemia.
authors.affiliation: From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (H.Z.); Division of Cardiology, School of Medicine, University of California Los Angeles (T.Q. de A. V.); and Department of Medicine, Montreal Heart Institute Research Center, Université de Montréal, Montreal, Quebec, Canada (C.M.). hz2418@cumc.columbia.edu tvallim@mednet.ucla.edu catherine.martel@icm-mhi.org.
authors.forename: Hanrui
authors.initials: H
authors.lastname: Zhang
authors.affiliation: From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (H.Z.); Division of Cardiology, School of Medicine, University of California Los Angeles (T.Q. de A. V.); and Department of Medicine, Montreal Heart Institute Research Center, Université de Montréal, Montreal, Quebec, Canada (C.M.). hz2418@cumc.columbia.edu tvallim@mednet.ucla.edu catherine.martel@icm-mhi.org.
authors.forename: Thomas Q
authors.initials: TQ
authors.lastname: de Aguiar Vallim
authors.affiliation: From the Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (H.Z.); Division of Cardiology, School of Medicine, University of California Los Angeles (T.Q. de A. V.); and Department of Medicine, Montreal Heart Institute Research Center, Université de Montréal, Montreal, Quebec, Canada (C.M.). hz2418@cumc.columbia.edu tvallim@mednet.ucla.edu catherine.martel@icm-mhi.org.
authors.forename: Catherine
authors.initials: C
authors.lastname: Martel
mesh_terms: D001692:Biological Transport; D002784:Cholesterol / Q000097:blood; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors; D008076:Cholesterol, HDL / Q000008:administration & dosage / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D019587:Dietary Supplements; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy*; D000073659:Gain of Function Mutation; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000071518:Liver X Receptors / Q000819:agonists; D009525:Niacin / Q000627:therapeutic use; D020320:Oligoribonucleotides, Antisense / Q000627:therapeutic use; D000091362:PCSK9 Inhibitors; D000071449:Proprotein Convertase 9 / Q000097:blood / Q000235:genetics; D011994:Recombinant Proteins / Q000008:administration & dosage
chemical_list: D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D000071518:Liver X Receptors; C000605213:NR1H3 protein, human; D020320:Oligoribonucleotides, Antisense; D000091362:PCSK9 Inhibitors; D011994:Recombinant Proteins; D009525:Niacin; D002784:Cholesterol; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9
keywords: PCSK9 protein; cardiovascular diseases; cholesterol; cholesterol, HDL; lipids; lipoproteins